← Eichor
Study identifier: NCT06858774 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder

Condition: Binge-Eating Disorder  ·  Sponsor: Icahn School of Medicine at Mount Sinai

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This project includes testing circadian reset technology (CRT) on frequency of binge eating in a sample of 40 individuals with binge eating disorder. Participants will be randomized to one of two groups. Both groups use a virtual reality (VR) headset for 10 minutes (5 upon waking, 5 before sleep) daily for 1 month. One group will use the CRT software on the headset and the other group will use a software intended to be a control. Measures will be taken at baseline and 1-month. The researchers anticipate that use of CRT will improve sleep quality leading to increased appetitive control.

This description comes directly from the study's public registry record.

Talk to the study team

Tom Hildebrandt  ·  212-659-8673  ·  tom.hildebrandt@mssm.edu

Jessica Bibeau  ·  212-659-8673  ·  jessica.bibeau@mssm.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Psychiatry, Eating and Weight Disorders ProgramNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06858774